Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
Tel Aviv University
Tel Aviv, IsraelTel Aviv University-ko ikertzaileekin lankidetzan egindako argitalpenak (49)
2024
-
A plain language summary of publication of the efficacy and safety of individualized niraparib dosing based on baseline body weight and platelet count in the PRIMA/ENGOT-OV26/GOG-3012 trial
Future oncology (London, England), Vol. 20, Núm. 13, pp. 799-809
-
Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
Gynecologic Oncology, Vol. 187, pp. 128-138
-
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial
Gynecologic Oncology, Vol. 184, pp. 168-177
-
Stable semivortex gap solitons in a spin–orbit-coupled Fermi gas
Chaos, Solitons and Fractals, Vol. 179
2023
-
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
New England Journal of Medicine, Vol. 389, Núm. 4, pp. 335-347
-
Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents
Blood, Vol. 141, Núm. 3, pp. 219-230
-
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study
eClinicalMedicine, Vol. 63
-
Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome
Journal of Molecular Medicine, Vol. 101, Núm. 12, pp. 1587-1601
-
Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
Cancer, Vol. 129, Núm. 12, pp. 1846-1855
-
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Genome Medicine, Vol. 15, Núm. 1
-
The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus
eClinicalMedicine, Vol. 61
-
Towards an adiposity-related disease framework for the diagnosis and management of obesities
Reviews in Endocrine and Metabolic Disorders, Vol. 24, Núm. 5, pp. 795-807
-
Uncertainties and controversies in axillary management of patients with breast cancer
Cancer Treatment Reviews, Vol. 117
-
Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry
Journal of Thrombosis and Haemostasis, Vol. 21, Núm. 10, pp. 2811-2823
2022
-
30-day morbidity and mortality of sleeve gastrectomy, Roux-en-Y gastric bypass and one anastomosis gastric bypass: a propensity score-matched analysis of the GENEVA data
International Journal of Obesity, Vol. 46, Núm. 4, pp. 750-757
-
Axillary surgery after neoadjuvant therapy in initially node-positive breast cancer: international EUBREAST survey
The British journal of surgery, Vol. 109, Núm. 9, pp. 857-863
-
Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, Núm. 1, pp. 24-33
-
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Obesity Facts, Vol. 15, Núm. 3, pp. 321-335
-
Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement
Clinical Nutrition, Vol. 41, Núm. 4, pp. 990-1000
-
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer
HemaSphere, Vol. 6, Núm. 8